Health
Study shows benefits of early anticlotting therapy in moderate COVID-19: International RAPID Trial could contribute to clinical practice – Science Daily
New research shows that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with…
COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering a full dose of a standard…
Continue Reading
-
Noosa News19 hours agoQueensland teachers strike for second time this year after rejecting 8 per cent wage rise
-
General19 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
General23 hours agoXi Jinping tells Donald Trump Taiwan’s ‘return to China’ is key to international post-war order
-
General22 hours agoLabor path to pass nature laws in last week narrows